Improved Ultrasound-Mediated Molecular Imaging of Previously Ischemic Mouse Myocardium Using Dual-Targeted Microbubbles and Constant Infusion

Molecularly targeted ultrasound contrast agents have been shown to identify previously-ischemic regions of the myocardium by targeting cell adhesion molecules that are displayed on activated endothelial surfaces in response to ischemia/reperfusion injury. An improved method for targeted microbubble (MB) delivery using constant infusion and dual targeted microbubbles is presented to enable better characterization of microbubble interaction with activated endothelium. Ten male C57BL/6 mice underwent 15-minute Left Anterior Descending (LAD) coronary occlusion followed by 2-hour reperfusion. Immediately after the 2-hour reperfusion, mouse hearts were imaged with a Sequoia scanner and 15L8 transducer. All mice received three of five MB preparations in random order: Sialyl Lewis X MB (MB<sub>X</sub>), anti-P-Selectin (MB<sub>P</sub>), anti-VCAM MB (MB<sub>V</sub>), Sialyl Lewis X + anti-VCAM MB (MB<sub>D</sub>), and isotype control MB (MB<sub>I</sub>). Subsequently, mouse hearts were excised and stained with TTC & Phthalo blue dyes to assess infarct size and area at risk, respectively. Video data indicated that the binding of targeted MB to ischemic regions was significantly higher for MB<sub>D</sub>, MB<sub>X</sub>, MB<sub>P</sub>, and MB<sub>V</sub>, compared to MB<sub>I</sub> (p<;0.05). Furthermore, normalized intensity for MB<sub>D</sub> was higher than both MB<sub>X</sub> and MB<sub>V</sub> (p<;0.05). Using Phthalo blue dye as the gold standard, receiver operating curve analysis demonstrated accurate detection of both ischemic and non-ischemic regions using MB<sub>D</sub> (AUC = 0.90), MB<sub>X</sub> (AUC = 0.89), MB<sub>P</sub> (AUC = 0.87), and MB<sub>V</sub> (AUC = 0.97).

[1]  J. Lindner,et al.  Detection of antecedent myocardial ischemia with multiselectin molecular imaging. , 2012, Journal of the American College of Cardiology.

[2]  M. Arditi,et al.  Effects of acoustic radiation force on the binding efficiency of BR55, a VEGFR2-specific ultrasound contrast agent. , 2012, Ultrasound in medicine & biology.

[3]  Paul A Dayton,et al.  An in vivo validation of the application of acoustic radiation force to enhance the diagnostic utility of molecular imaging using 3-d ultrasound. , 2012, Ultrasound in medicine & biology.

[4]  Kenneth Hoyt,et al.  A Triple‐Targeted Ultrasound Contrast Agent Provides Improved Localization to Tumor Vasculature , 2011, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[5]  Sanjiv S. Gambhir,et al.  Targeted Contrast-Enhanced Ultrasound Imaging of Tumor Angiogenesis with Contrast Microbubbles Conjugated to Integrin-Binding Knottin Peptides , 2010, Journal of Nuclear Medicine.

[6]  K. Ley,et al.  Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[7]  J. Lindner,et al.  Detection of recent myocardial ischaemia by molecular imaging of P-selectin with targeted contrast echocardiography. , 2007, European heart journal.

[8]  Eric Tom,et al.  Myocardial Ischemic Memory Imaging With Molecular Echocardiography , 2007, Circulation.

[9]  S. Acton,et al.  Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow. , 2006, Contrast media & molecular imaging.

[10]  Klaus Ley,et al.  Deformable gas-filled microbubbles targeted to P-selectin. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Paul A Dayton,et al.  Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[12]  William R Wagner,et al.  Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx. , 2005, Biotechnology and bioengineering.

[13]  Sriram Neelamegham,et al.  Affinity and kinetics of sialyl Lewis-X and core-2 based oligosaccharides binding to L- and P-selectin. , 2005, Biochemistry.

[14]  Susannah H Bloch,et al.  Radiation-Force Assisted Targeting Facilitates Ultrasonic Molecular Imaging , 2004, Molecular imaging.

[15]  Klaus Ley,et al.  Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[16]  William R Wagner,et al.  Ultrasound Imaging of Acute Cardiac Transplant Rejection With Microbubbles Targeted to Intercellular Adhesion Molecule-1 , 2003, Circulation.

[17]  Harald Becher,et al.  Echoscintigraphy: a new imaging modality for the reduction of color blooming and acoustic shadowing in contrast sonography. , 2003, Ultrasound in medicine & biology.

[18]  W. Wagner,et al.  Microbubble‐Endothelial Cell Interactions as a Basis for Assessing Endothelial Function , 2002, Echocardiography.

[19]  K. Ley,et al.  Ultrasound Assessment of Inflammation and Renal Tissue Injury With Microbubbles Targeted to P-Selectin , 2001, Circulation.

[20]  R Ruthazer,et al.  Missed diagnoses of acute cardiac ischemia in the emergency department. , 2000, The New England journal of medicine.

[21]  S. Kaul,et al.  Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes. , 2000, Circulation.

[22]  S. Kaul,et al.  Imaging of Myocardial Perfusion with SonoVue™ in Patients with a Prior Myocardial Infarction , 1999 .

[23]  M. Suematsu,et al.  Recognition of consensus CHO structure in ligands for selectins by novel antibody against sialyl Lewis X. , 1995, The American journal of physiology.

[24]  S. Kaul,et al.  Imaging of Myocardial Perfusion with SonoVuetrade mark in Patients with a Prior Myocardial Infarction. , 1999, Echocardiography.